Moreover, a comparison of the number of animals with unhealed defects (all controls) or healed defects (complete bony continuity across the defect site) showed that besides pentadecapeptide intramuscular application for 14 days (i.e., local application of bone marrow or autologous cortical graft), also following other pentadecapeptide BPC-157 regimens (local application, or intermittent intramuscular administration), the number of animals with healed defect was increased
J Cell Physiol 234(12):2337923387
Furthermore, proper solvent selection directly impacts the structural homology of fragile molecular chains
Results vary based on individual metabolism, dosage, frequency, and lifestyle habits
This compounded product should only be used for an approved medical purpose under close medical supervision, with follow-up lab testing as directed.